Contract 75A50120C00177

Vedanta Biosciences, Inc. · Department Of Health And Human Services · September 25, 2020

Cost SharingFull & Open CompetitionNAICS 541714

Vedanta Biosciences, Inc. was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 25, 2020 for $61.15 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Boston, MA. It was awarded under full and open competition. The contract has been modified 5 times since the base award It uses cost sharing contract pricing. The most recent modification was on June 30, 2026. If all options are exercised, the contract could reach $134.15 million.

Obligated to date
$61.15M
$61,146,088
Current value
$99.15M
Potential value
$134.15M
if all options exercised
Modifications
5
Latest June 30, 2026

Contract details

PIID
75A50120C00177
Award type
Definitive Contract
Pricing
Cost Sharing
Set-aside
No Set Aside Used.
Competition
Full And Open Competition
NAICS
541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
Product / service
R&D- Other Research And Development (Advanced Development)
Place of performance
Boston, MA
First action
September 25, 2020
Latest action
June 30, 2026

Description

EO14042 TO DEVELOP MEDICAL COUNTERMEASURES (MCMS) THAT TREAT ANTIBIOTIC RESISTANT INFECTIONS.

Modification timeline

  • June 30, 2026
    Mod P00017 · Supplemental Agreement For Work Within Scope
    $99.15M
  • December 3, 2025
    Mod P00015 · Supplemental Agreement For Work Within Scope
    $79.15M
  • September 23, 2025
    Mod P00014 · Other Administrative Action
    $79.15M
  • July 17, 2024
    Mod P00011 · Supplemental Agreement For Work Within Scope
    $61.15M
  • September 30, 2021
    Mod P00003 · Exercise An Option
    TO DEVELOP MEDICAL COUNTERMEASURES (MCMS) THAT TREAT ANTIBIOTIC RESISTANT INFECTIONS.
    $51.15M
  • September 25, 2020
    Base award
    TO DEVELOP MEDICAL COUNTERMEASURES (MCMS) THAT TREAT ANTIBIOTIC RESISTANT INFECTIONS.
    $51.15M

Similar contracts

RecipientAgencyDateObligated
Battelle Memorial InstituteDepartment Of Health And Human ServicesJuly 2, 2026$6.28M
Glaxosmithkline, LlcDepartment Of Health And Human ServicesJuly 2, 2026$597.8K
Medigen, Inc.Department Of Health And Human ServicesJuly 2, 2026$2.18M
American Type Culture CollectionDepartment Of Health And Human ServicesJuly 1, 2026$855.4K
Battelle Memorial InstituteDepartment Of Health And Human ServicesJuly 1, 2026$11.71M
Battelle Memorial InstituteDepartment Of Health And Human ServicesJuly 1, 2026$3.49M

Top contractors in NAICS 541714

Lifetime obligated dollars across all federal contracts in this NAICS code.

Track this on BesaGov

Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.

✓ You’re on the list. We’ll never spam you.

Helpful guides

Continue learning

See all guides →
More on BesaGov

Keep researching

Track this contract, set alerts on similar opportunities, and build proposal pipelines on BesaGov.
Sign up free

Frequently asked questions

What is contract 75A50120C00177?

Contract 75A50120C00177 is a federal contract awarded to Vedanta Biosciences, Inc. by Department Of Health And Human Services on September 25, 2020 for $61.15 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 5 times since the base award.

Who won contract 75A50120C00177?

Vedanta Biosciences, Inc. won contract 75A50120C00177 from Department Of Health And Human Services.

How much is contract 75A50120C00177 worth?

Contract 75A50120C00177 has obligated $61.15 million to date, with a total potential value of $134.15 million if all options are exercised.